Bloomberg Originals
Bloomberg Originals
@business·5.1M subscribers·49.4K videos

China’s Brain-Chip Startups Are Rushing to Commercialize BCI Tech

Posted

June 10, 2026

Views

13,213

Likes

542

Comments

4

Engagement

4.13%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

Controlling devices with your thoughts is no longer science fiction. China's neurotech ecosystem is advancing rapidly—with regulators having just approved its first commercial BCI.

The latest episode of Primer takes you inside Shanghaibased startup NeuroXess as they run a yearlong trial

--------

Like this video? Subscribe

Get unlimited access to Bloomberg.com for just $1.99 your first month

Bloomberg Originals offers bold takes for curious minds on today’s biggest topics. Hosted by experts covering stories you haven’t seen and viewpoints you haven’t heard, you’ll discover cinematic, data-led shows that investigate the intersection of business and culture. Exploring every angle of climate change, technology, finance, sports and beyond, Bloomberg Originals is business as you’ve never seen it.

Subscribe for business news, but not as you've known it: exclusive interviews, fascinating profiles, data-driven analysis, and the latest in tech innovation from around the world.

Visit our partner channel Bloomberg News for global news and insight in an instant.

Guests & Subjects Covered

BCI TheSubscribe GetBloomberg News

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

China’s Brain-Chip Startups Are Rushing to Commercialize BCI Tech · Bloomberg Originals · Sentinel